EcoDrugPlus

Tachykinin Receptor 3

Ensembl ID : ENSNFUG00015001541
Gene Symbol: TACR3
3 Cross references
208 Possible Orthologues:

Thromboxane A Synthase 1 (Platelet)

Ensembl ID : ENSNFUG00015005471
Gene Symbol: TBXAS1
1 Cross references
217 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSNFUG00015024846
Gene Symbol: TBXA2R
1 Cross references
192 Possible Orthologues:

Thromboxane-A Synthase-Like

Ensembl ID : ENSNFUG00015017146
Gene Symbol: LOC107395858
3 Cross references
214 Possible Orthologues:

Thymidine Phosphorylase

Ensembl ID : ENSNFUG00015011657
Gene Symbol: TYMP
1 Cross references
172 Possible Orthologues:

Thymidylate Synthetase

Ensembl ID : ENSNFUG00015005744
Gene Symbol: TYMS
3 Cross references
224 Possible Orthologues:

Thyroid Hormone Receptor Beta

Ensembl ID : ENSNFUG00015014216
Gene Symbol: THRB
3 Cross references
388 Possible Orthologues:

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSNFUG00015002934
Gene Symbol: TRHR
3 Cross references
201 Possible Orthologues:

Tissue Factor-Like

Ensembl ID : ENSNFUG00015014342
Gene Symbol: LOC107372568
3 Cross references
199 Possible Orthologues:

Toll Like Receptor 7

Ensembl ID : ENSNFUG00015009290
Gene Symbol: TLR7
1 Cross references
197 Possible Orthologues:

Toll Like Receptor 8

Ensembl ID : ENSNFUG00015009237
Gene Symbol: TLR8
1 Cross references
187 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSNFUG00015009419
Gene Symbol: TAAR1
3 Cross references
398 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).